|
BioScreening - organic compounds for screening
Proteomics NewsKINAXO’s Cellular Target Profiling® reveals mTOR as a new target of Celebrex - Martinsried, Germany, April 29, 2009 / b3c newswire / - Kinaxo Biotechnologies GmbH has successfully applied its Cellular Target Profiling® technology to identify the protein kinase mTOR as a new cellular target of celecoxib (Celebrex®, Pfizer). Celecoxib is a non-steroidal, anti-inflammatory Cox-2 inhibitor approved for the treatment of osteoarthritis, rheumatoid arthritis [...]
Molecular Fingerprints Point The Way To Earlier Cancer Diagnosis And More Targeted Treatment - ScienceDaily (Mar. 27, 2009) — Metabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer.
You’ve likely heard about metabolites; your physician probably screens for some known ones such as triglycerides or cholesterol at your annual physical. Scientists suspect we have about 3,000 [...]
AnaSpec Introduces New SensoLyteTM MMP ELISA Kits - San Jose, CA October 16, 2008
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated zinc endopeptidases involved in both normal and diseased tissue remodeling. They are capable of degrading all kinds of extracellular matrix (ECM) proteins, but also can process a number of bioactive molecules. MMPs are key players in normal and pathological [...]
Thermo Fisher Scientific Holds European Proteomics Seminar Series on Protein Quantitation - SAN JOSE, Calif. (October 15, 2008) - Thermo Fisher Scientific Inc., the
world leader in serving science, today announced the dates for its 2008
European Proteomics Seminar Series. The series, which takes place throughout
October and November, has become an established venue for scientific and
technological discussion and the sharing of practical tips.
The theme of the 2008 seminar series [...]
Biological Drugs Spurring an Evolution in Injectable Drug Delivery - (Amherst, NH) - The success of recombinant protein drugs such as Enbrel, Remicade, and Herceptin in treating refractory conditions is fueling the search for protein and peptide-based therapeutic agents in oncology, inflammation and a host of other disease classes. Led by the proliferation of antibody-based drug candidates, biological drugs as a class continue to outpace [...]
7th Annual Protein Kinases Congress 10-12 March 2008 in Crowne Plaza Berlin City Centre, Berlin, Germany - Innovating kinase inhibitor development is the key to successful clinical development. At Informa Life Sciences 7th Annual Protein Kinases Congress hear the latest thinking and strategies towards creating a selective inhibitor. Learn about new targets, industry trends in structure-based drug design, clinical case-studies and discuss the issue of cardiotoxicity.
For more information visit: http://www.iir-events.com/IIR-Conf/page.aspx?id=9547
PepCon-2008 Shenzhen, China on April 22-24, 2008 - Advances in peptide and protein researches are occurring at an ever increasing pace, in a wide range of fields and scientific disciplines. At this exciting time, it is especially important to promote scientific and technological exchange and cooperation at the international level.
To establish of a new educational and networking platform for protein and peptide [...]
Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog - NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ — Strategic Diagnostics Inc. — today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI’s proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at http://antibodies.sdix.com [...]
Proteomic profiling to assess genetically modified crop safety - Wednesday, January 11, 2006
By Sirpa O. Kärenlampi and Satu J. Lehesranta
It is generally accepted that traditional food is safe for the majority of consumers. For the introduction of a new variant or cultivar developed from a traditional crop plant, maximum limits have been set in some cases, e.g., for potato and oilseed rape, to the [...]
|
|
